NIH begins study of vaccine to protect against mosquito-borne diseases

The National Institute of Allergy and Infectious Diseases, has launched a Phase 1 clinical trial to test an investigational vaccine intended to provide broad protection against a range of mosquito-transmitted diseases, such as Zika, malaria, West Nile fever and dengue fever, and to hinder the ability of mosquitoes to transmit such infections. The study, conducted at the NIH Clinical Center in Bethesda, Maryland, will examine the vaccine's safety and ability to generate an immune response.

What feeling does this article give you?

#hashtags to follow:

Phase 1 [+]    Zika [+]    West Nile [+]    NIH Clinical Center [+]    Bethesda [+]    Maryland [+]   

More #news: